Literature DB >> 8883743

Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates.

N A Beischer1, P Wein, M T Sheedy, B Steffen.   

Abstract

We wished to determine whether gestational diabetes was associated with an increased perinatal mortality rate, and to investigate the cause for the observed increase in the incidence of gestational diabetes. We therefore reviewed the results of glucose tolerance tests and pregnancy outcome in 116,303 pregnancies, 1971-1994, at the Mercy Hospital for Women. The main outcome measurements were the presence or absence of gestational diabetes, and perinatal mortality. Over the entire period of the study, gestational diabetes was associated with an increased risk of perinatal mortality (Mantel-Haenszel adjusted odds ratio 1.53, 95% CI 1.13-2.06, p = 0.0069). Women with gestational diabetes that was only diagnosed retrospectively had a higher perinatal mortality rate than their contemporaries with normal glucose tolerance (OR 2.31, 95% CI 1.37-3.91, p = 0.0025). Women in whom a glucose tolerance test was not performed continued to have a higher perinatal mortality rate than women who were tested (adjusted OR 2.21, 95% CI 1.56-3.12, p < 0.00001). There has been an increase in the prevalence of gestational diabetes from 2.9% to 8.8%. Some of this is due to changes in population characteristics (increases in maternal age, obesity and proportion from South-East Asia), but there was still an independent increase over time. We conclude that identification and treatment of women with gestational diabetes can reduce perinatal mortality rates. Similarly to diabetes mellitus in the total population, the prevalence of gestational diabetes has increased over time.

Entities:  

Mesh:

Year:  1996        PMID: 8883743     DOI: 10.1111/j.1479-828x.1996.tb02703.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  16 in total

Review 1.  Stillbirth in the pregnancy complicated by diabetes.

Authors:  Roman Starikov; Donald Dudley; Uma M Reddy
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

Review 2.  The increasing prevalence of diabetes in pregnancy.

Authors:  Kelly J Hunt; Kelly L Schuller
Journal:  Obstet Gynecol Clin North Am       Date:  2007-06       Impact factor: 2.844

3.  Engagement with and outcomes of a Midwifery-led intervention group for pregnant women of high body mass index.

Authors:  Sarah R Chwah; Amanda Reilly; Beverley Hall; Anthony J O'Sullivan; Amanda Henry
Journal:  Obstet Med       Date:  2016-04-29

4.  Discrepancy in Insulin Regulation between Gestational Diabetes Mellitus (GDM) Platelets and Placenta.

Authors:  Yicong Li; Anthonya Cooper; Imelda N Odibo; Asli Ahmed; Pamela Murphy; Ruston Koonce; Nafisa K Dajani; Curtis L Lowery; Drucilla J Roberts; Luc Maroteaux; Fusun Kilic
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

5.  Gestational diabetes mellitus screening and outcomes.

Authors:  Hale Lebriz Aktün; Derya Uyan; Betül Yorgunlar; Mustafa Acet
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-03-01

6.  Potential impact of American Diabetes Association (2000) criteria for diagnosis of gestational diabetes mellitus in Spain.

Authors:  W Ricart; J López; J Mozas; A Pericot; M A Sancho; N González; M Balsells; R Luna; A Cortázar; P Navarro; O Ramírez; B Flández; L F Pallardo; A Hernández; J Ampudia; J M Fernández-Real; R Corcoy
Journal:  Diabetologia       Date:  2005-05-12       Impact factor: 10.122

7.  Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study.

Authors:  Suresh Babu Naraharisetti; Brian J Kirby; Mary F Hebert; Thomas R Easterling; Jashvant D Unadkat
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-10-22       Impact factor: 3.205

Review 8.  Work-up of stillbirth: a review of the evidence.

Authors:  Robert M Silver; Michael W Varner; Uma Reddy; Robert Goldenberg; Halit Pinar; Deborah Conway; Radek Bukowski; Marshall Carpenter; Carol Hogue; Marian Willinger; Donald Dudley; George Saade; Barbara Stoll
Journal:  Am J Obstet Gynecol       Date:  2007-05       Impact factor: 8.661

9.  Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum.

Authors:  Si-ming Li; Wen-fei Wang; Li-hong Zhou; Lei Ma; Ying An; Wen-juan Xu; Tian-he Li; Yin-hang Yu; De-shan Li; Yan Liu
Journal:  Endocrine       Date:  2014-06-04       Impact factor: 3.633

Review 10.  The management of gestational diabetes.

Authors:  N Wah Cheung
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.